Myasthenia gravis (MG) is a heterogeneous autoimmune disease, which characterized by postsynaptic neuromuscular transmission defect, with antibodies directly targeting the acetylcholine receptor (AChR) or other structural proteins of junction. The majority MG cases are associated thymic pathologies, including thymoma, thyroiditis, diseases malignant hematologic neoplasia. present study reported...